Home | Business News | Browse by Publication | B | Biotech Business

HAWAII BIOTECH BEGINS PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE.

Publication: Biotech Business
Publication Date: 01-OCT-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Hawaii Biotech, Inc. President and CEO Elliot Parks, Ph.D., has announced that the company has initiated a Phase 1 clinical study with their monovalent dengue vaccine candidate. The double-blind, placebo controlled, dose escalation safety study in healthy subjects is being conducted at the Saint Louis University Center for Vaccine Development. http://vaccine.slu.edu/ Vaccine recipients in this study will also be monitored for virus neutralizing antibodies.

"This dengue clinical study is an important milestone in Hawaii...

Access Full Article, Compliments of Goliath

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.